Methylation Score Can ID Risk for Cervical Adenocarcinomas
Methylation score had sensitivity of 74 percent, specificity of 89 percent for adenocarcinoma in situ/adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.